The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA.

The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA. - The characteristics of Japanese SCCmec type II and type IV MRSA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023232

Enrollment

280

Registered

2016-07-20

Start date

2015-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRSA infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients from whom SCCmec type II or type IV MRSA was isolated between December 2014 and October 2015(only from skin and soft tissue or lower respiratpry tract specimens)

Exclusion criteria

Exclusion criteria: patients who were treated at the neonatal intensive care unit or growing care unit

Design outcomes

Primary

Measure	Time frame
the clinical differences between SCCmec type II and type IV MRSA infection	—

Secondary

Measure	Time frame
1.patients' characteristics(age, sex, comorbidity, community-associated/health care-associated) 2.antimicrobial susceptibility 3.distribution of patogenic genes (sea,seb,sem,seo,tst)	—

Countries

Japan

Contacts

Public ContactFujiko Mitsumoto-Kaseida

Kyushu University Hospital Department of General Internal Medicine

mitsu-f@gim.med.kyushu-u.ac.jp092-642-5909

Outcome results